Proof of Usefulness Report

UMotif

Analysis completed on 2/20/2026

+564
Proof of Usefulness Score
Industry Mainstay

uMotif is a verifiable, high-traction Series B company (approx. $35M+ funding) with significant partnerships (AstraZeneca, Syneos Health) in the decentralized clinical trial space. While the project itself demonstrates exceptional real-world utility and market relevance, the submission quality was critically poor, featuring false claims ('most people have used my product') and inaccurate data. This disconnect resulted in severely penalized Quality Factors (Qi), reducing the score from a potential 750+ (typical for this scale) to the 500s.

Ready to Compete for $150k+ in Prizes?

Move this data into a HackerNoon blog draft to become eligible for your share of $150k+ in cash and software prizes

View All Reports

Score Breakdown

Real World Utility+230.0
Audience Reach Impact+65.0
Technical Innovation+120.0
Evidence Of Traction+112.5
Market Timing Relevance+90.0
Functional Completeness+2.5
Subtotal+620
Usefulness Multiplierx0.91
Final Score+564

Project Details

Project URL
umotif.com
Description
uMotif's mission is to put patients at the center of clinical research. Designed with patients for patients, the uMotif patient-first eClinical platform powers site-based to fully decentralized clinical, real-world, and post-marketing research. By engaging patients and healthcare professionals, uMotif is trusted by global pharmaceutical companies, biotechs, CROs, and academic institutions to capture large volumes of eCOA/ePRO, symptom, and wearable device data. www.umotif.com

Algorithm Insights

Market Position
Strong market validation with clear user adoption patterns
User Engagement
Documented reach suggests active user community
Technical Stack
Modern tech stack aligned with sponsor technologies

Recommendations to Increase Usefulness Score

Document User Growth

Provide specific metrics on user acquisition and retention rates

Showcase Revenue Model

Detail sustainable monetization strategy and current revenue streams

Expand Evidence Base

Include testimonials, case studies, and third-party validation

Technical Roadmap

Share development milestones and feature completion timeline